]>
IRCT20170705034915N3 IRCT 2019-08-23 MIMDaroo Pharmaceutical Co. Study of the effect of MigraineCut drug on migraine headaches Investigation of the effectiveness of MigraineCut on the intensity, duration and frequency of migraine headaches of migraineurs referring to Aramesh Tehran pain clinic 2019-04-19 anticipated 492 Complete https://irct.ir/trial/40483 interventional Randomization: N/A, Blinding: Not blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment. N/A Migraine. Intervention 1: Migraine patients: Use of MigraineCut nasal spray containing extract of herbs intended to reduce headaches indices and clinical signs of migraine within 120 days at an authorized dose of a puff in every nasal cavity every 3 hours. Intervention 2: Control group: Migrainures group with no treatment. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is It is not yet known if there will be a plan to make this available.
public Farid Semsarha
No. 4, 4th Street, Ganbarzadeh Street, Shahid Beheshti Street, Tehran, Iran
Tehran Iran (Islamic Republic of) 1533754716 +98 21 9662 1410 fsemsarha@mimdaroo.com MIMDaroo Pharmaceutical Co. scientific Farid Semsarha
No. 4, 4th Street, Ganbarzadeh Street, Shahid Beheshti Street, Tehran, Iran
Tehran Iran (Islamic Republic of) 1533754716 +98 21 9662 1410 fsemsarha@mimdaroo.com MIM Daroo Iran (Islamic Republic of) Patient with migraine after being diagnosed by a neurologist. Male or female patient has a migraine attack at least one month per year. Patient aged between 16 and 60 years who has the opportunity to complete the diary form and communicate effectively with the counselor. Patient that doesn't have susceptibility to herbal medicines. 16 years 60 years Both Patient with probable migraine headaches Patients with medication overused headaches Patients with complex headaches Patients who provide incomplete data and information to the counselor. Patients who do not wish to start or continue treatment with knowledge of the conditions of the study G43 Migraine Treatment - Drugs Other Migraine patients: Use of MigraineCut nasal spray containing extract of herbs intended to reduce headaches indices and clinical signs of migraine within 120 days at an authorized dose of a puff in every nasal cavity every 3 hours. Control group: Migrainures group with no treatment Headeches frequency. Timepoint: Counting the number of headaches from the beginning of the study (before the intervention), 30, 60, 90, and 120 days after the start of the MigraineCut. Method of measurement: headache diary form. Headache intensity. Timepoint: Record the intensity of each migraine attack every month for up to 4 months during the study. Method of measurement: Headache diray form. Headache duration. Timepoint: Calculate the duration of headaches before the intervention, and during 30, 60, 90, and 120 days from the onset of intervention with cutaneous migraine. Method of measurement: Headache diray form. Changes in the clinical symptoms of migraineurs. Timepoint: Clinical symptoms of patients, such as sensitivity to light and sound before intervention, and 30, 60, 90, and 120 days after intervention are investigated. Method of measurement: Headache diary form and expert visit. MIMDaroo Pharmaceutical Co. Approved 2019-04-17 Ethics committee of azad University-Research and science branch Floor 13, Unit A, Central Headquarters of the Ministry of Health Education, Between South Falamak and Zarafshan, Simay Iran Avenue, Ghods Town, Tehran, Iran Tehran Tehran Iran (Islamic Republic of)